C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
NMYSF Equity

NMYSF

OTCMKTS · NMYSF

$0.75
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
54/100 composite
Fundamentals72
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

NamSys Inc (OTC: NMYSF) has been assigned a Neutral rating, positioned within the Neutral band with a conviction level of 2 out of 5. The company's fundamental strengths largely drive this assessment, contributing significantly to the overall score of 54.2. While the fundamentals pillar stands out markedly with a robust score, regulatory compliance supports stability but does not offer additional upward traction. Meanwhile, both market and editorial factors demonstrate limited influence, with lukewarm enthusiasm from the broader market scope.

The underlying data supporting this assessment reveals modest yet consistent revenue growth year-over-year. The company's gross and operating margins remain notably high, underscoring efficiency in its operations. A market capitalization just above 20 million USD places NamSys within a smaller tier, while the financial condition remains stable, bolstered by positive EBITDA figures and favorable net income. Despite these strong operational indicators, regulatory adherence seems regular with no significant jurisdiction events or enforcement issues, demonstrating sound compliance yet lacking recent filings that could drive regulatory momentum.

Looking ahead, the most critical factor that could enhance NamSys's outlook is a sustained improvement in regulatory engagement. The company's stable compliance record needs a proactive strategy for leveraging its jurisdictional position in Canada to potentially capitalize on regulatory modifications or expansions. Consequently, investors should keep a vigilant eye on any shifts in filing activity and policy changes that may open avenues for further growth.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
CEO
Jason Siemens
CFO
Christopher J. Adams
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$20.1M
Enterprise value
$16.6M
P/E ratio
12.5
Price to book
3.62
Price to sales
2.45
EV / EBITDA
7.11
Revenue (TTM)
$8.2M
Gross profit (TTM)
$5.2M
EBITDA
$3.3M
Operating margin
39.3%
Profit margin
30.9%
Rev growth YoY
6.1%
Return on equity
29.1%
Return on assets
20.9%
EPS (TTM)
$0.06
Shares outstanding
26.9M
Insider ownership
38.2%
Institutional ownership
10.4%
Beta
-0.36
GICS sector
Technology
GICS industry
Software - Application
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for NMYSF (NMYSF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for NMYSF (NMYSF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Event-Driven Opportunity. Setup improving. Long-term outperformer detected. (2 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for NMYSF are maintained by Cannabis Investor News and refreshed throughout the trading day.